The Whipple procedure, used to remove tumors from pancreatic cancer patients, is one of surgery's most extensive and challenging operations. Now, surgeons are using a minimally invasive robotic surgical system to perform the surgery. ...
Tags: Minimally Invasive Robotic Surgical System, Whipple Procedure
Bedding major Simmons said it will be a major sponsor of Howard Young's 2013 Atlanta Golf Classic, supporting pancreatic cancer research. Atlanta-based Simmons will co-sponsor the charity golf tournament, which expects to attract 120 ...
Tags: Light Industry, Daily Use
Celgene International has obtained FDA priority review status for Abraxane (paclitaxel protein-bound particles for injectable suspension) supplemental new drug application (sNDA). The application covers the use of Abraxane and gemcitabine ...
Tags: Celgene sNDA, FDA Priority
US medical center, Mayo Clinic, has signed a pre-clinical research agreement with MagForce. Under the agreement, Mayo Clinic will begin a research program to investigate the preclinical efficacy of the MagForce's NanoTherm therapy in ...
NewLink Genetics HyperAcute-Pancreas Immunotherapy (algenpantucel-L) has gained European orphan designation. Orphan designation provides NewLink with access to multiple incentives for drug development in EU. Incentives include decreased ...
Tags: algenpantucel-L, NewLink Genetics, HyperAcute-Pancreas Immunotherapy
Skuldtech and AB Science have discovered a new set of blood markers predictive of a higher survival rate in pancreatic cancer patients. The companies are also planning to use the new markers for future companion test commercialization ...
Tags: skuldtech, AB science, blood markers, pancreatic cancer patients
Celgene International Sàrl Abraxane, an albumin-bound form of paclitaxel, has demonstrated statistically significant improvementin overall survival for advanced pancreatic cancer patients in Phase III study. The Metastatic ...